Floatz logo

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE

Herpes Zoster Pain

Shirong TanSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Herpes Zoster Pain cohort.

Asset / SponsorPhaseRating
Capsaicin
NeurogesX
Phase 3BBB
Zoster Vaccine Recombinant, Adjuvanted
GlaxoSmithKline
Phase 4BBB
ZOSTER VACCINE, LIVE, (OKA/MERCK)
Louis Stokes VA Medical Center
Phase 4BBB
Pregabalin
CMH Kharian Medical College
Phase 4BB
aciclovir
Cttq
Phase 4BB

View all 26 →

Same molecule, other indications

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:

Pain, PostoperativeDormant
BBB
Indicative ·
78 / 100
View asset →
Anesthesia, LocalDormant
BBB
Indicative ·
76 / 100
View asset →
neuralgiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →